Get started
Author

Cathy Rowe

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 390
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
2020 · Mark Ainsworth, Monique Andersson, et al. · The Lancet Infectious Diseases · 341
PDF
Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure
2022 · Catherine J. Reynolds, Corinna Pade, et al. · Science · 325
COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing
2021 · Tim Peto, Dominic Affron, et al. · EClinicalMedicine · 235
PDF
Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals
2023 · Ashley D. Otter, Scott Jones, et al. · Nature Communications · 58
PDF
Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara–Bavaria Nordic vaccine against mpox in children: a national outbreak response
2023 · Shamez N Ladhani, Alexander C Dowell, et al. · The Lancet Infectious Diseases · 43
PDF
mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant
2021 · Helen Parry, Gokhan Tut, et al. · eLife · 35
Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis
2023 · Christopher A. Martin, Joshua Nazareth, et al. · EClinicalMedicine · 31
PDF
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
2021 · Helen X. Chen, Minkyung Song, et al. · Clinical Cancer Research · 29
Comparability of six different immunoassays measuring SARS‐CoV ‐2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction
2021 · Abigail Lamikanra, Dung Nguyen, et al. · Transfusion · 27
PDF
Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study
2025 · Scott Jones, Bethany Hicks, et al. · The Lancet Microbe · 24
Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort
2023 · Peter D. Kirwan, Victoria J. Hall, et al. · The Lancet Regional Health - Europe · 19
Impact of COVID-19 Vaccination Program on Seroprevalence in Blood Donors in England, 2021
2021 · Heather J Whitaker, Suzanne Elgohari, et al. · Journal of Infection · 19
PDF
COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study
2023 · Heather J. Whitaker, Ruby S.M. Tsang, et al. · Journal of Infection · 18
PDF
BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant
2021 · Helen Marie Parry, Gokhan Tut, et al. · SSRN Electronic Journal · 17
Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of response
2025 · Philip G Drennan, Nicholas M Provine, et al. · The Lancet Microbe · 15
PDF
Evaluation of a multiplexed immunoassay for assessing long-term humoral immunity Orthopoxviruses
2024 · Bethany Hicks, Scott Jones, et al. · Vaccine · 14
Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
2022 · Ivan Doykov, Tomas Baldwin, et al. · Cell Reports Methods · 11
Determinants of SARS-CoV-2 anti-spike antibody levels following BNT162b2 vaccination: cross-sectional analysis of 6,000 SIREN study participants
2022 · Ashley David Otter, Silvia D’Arcangelo, et al. · medRxiv · 11
PDF
Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom’s COVID-19 Public Health Response
2022 · Ashley David Otter, Abbie Bown, et al. · Microbiology Spectrum · 8
Limitations of mpox lateral flow tests in assessing orthopoxvirus immunity
2024 · Toby Jones, Scott Jones, et al. · The Lancet Infectious Diseases · 2
PDF
Evaluating the use of the first WHO International Standard for anti-SARS-CoV-2 immunoglobulin to harmonise the readouts between commercial SARS-CoV-2 binding antibody tests: the HARMONY multicentre calibration study
2022 · Amanda Semper, Peter Rigsby, et al. · The Lancet Microbe · 2
The Quality Control of Animal Cell Lines and the Prevention, Detection and Cure of Contamination
2011 · Peter Thraves, Cathy Rowe · Wiley eBooks · 2
The impact of ethnicity on longitudinal humoral and cellular immune responses to SARS-CoV-2 booster vaccination
2026 · Christopher A. Martin, Joshua Nazareth, et al. · Scientific Reports · 1
PDF
Cohort Profile: SARS-CoV-2 Immunity and Reinfection EvaluatioN (SIREN)
2026 · Sarah Foulkes, Katie Munro, et al. · International Journal of Epidemiology · 1
Works count: 30
Citation count: 1,679
H-index: 15
I10-index: 19
Year
Topic
Type